Cargando…
Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
Before the sorafenib era, advanced but liver-confined hepatocellular carcinoma (HCC) was treated by liver-directed therapy. Hepatic arterial concurrent chemoradiotherapy (CCRT) has been performed in our group, giving substantial local control but frequent failure. The aim of this study was to analyz...
Autores principales: | Cha, Hyejung, Yoon, Hong In, Lee, Ik Jae, Koom, Woong Sub, Han, Kwang-Hyub, Seong, Jinsil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823771/ https://www.ncbi.nlm.nih.gov/pubmed/23633620 http://dx.doi.org/10.1093/jrr/rrt034 |
Ejemplares similares
-
Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy
por: Choi, Yunseon, et al.
Publicado: (2014) -
Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Yoon, Hong In, et al.
Publicado: (2016) -
Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
por: Lee, Ik Jae, et al.
Publicado: (2014) -
The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma
por: Yoon, Hong In, et al.
Publicado: (2016) -
Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
por: Cha, Jihye, et al.
Publicado: (2013)